Effectiveness of and Implementation Strategies for 'Disfrutando'.
Disfrutando 2
1 other identifier
interventional
31
1 country
2
Brief Summary
Despite much research that has focused on enhancing type 2 diabetes mellitus (T2DM) health outcomes for high burden populations, more remains to be done. There is a need to develop practical approaches that not only equip people with knowledge about T2DM self-management, but also help them mitigate the adverse social determinants of health (SDOH) that are fueling the burgeoning numbers of people in the United States with T2DM and that are preventing them from practicing healthful behaviors. This study will examine an intervention named 'Disfrutando' that strives to help people prevent and manage T2DM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2025
CompletedFirst Posted
Study publicly available on registry
June 17, 2025
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
ExpectedMay 7, 2026
June 1, 2025
10 months
May 29, 2025
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glucose (Blood Sugar) Control
Name of measurement: Hemoglobin A1c (HbA1C) How measured/assessed: HbA1C is a biomedical test that provides average glucose (blood sugar) level over the past 8 to 12 weeks and is used to help manage diabetes. Glucose (blood sugar) control will be evaluated using the A1CNow Self Check device. This FDA-cleared device is sold over the counter and is a portable, self-check test that is self-administered using a small fingerstick blood sample. Results are obtained in 5 minutes.
Hemoglobin A1C will be measured at baseline (pre-intervention), 12 weeks, and 6 months.
Secondary Outcomes (2)
Change in Body Weight
Body weight will be measured weekly for 6 weeks, at 12 weeks, and at 6 months. The same scale will be used at all time points.
Self-efficacy for diabetes self-care management
Self-efficacy will be measured at pre-intervention, 12 weeks, and 6 months
Study Arms (2)
Intervention Group
EXPERIMENTALBehavioral Intervention
Waitlist Group
EXPERIMENTALThis arm will receive the intervention after the waitlist period
Interventions
Disfrutando is a six-week, weekly intervention with a booster intervention at week 12. Intervention content includes glucose control with individual goals, glucose monitoring and glucometer practice, healthy eating demonstrations, benefits of physical activity, prevention and management of T2DM. The intervention has a strong focus on mitigating barriers and challenges to diabetes self-care management.
Eligibility Criteria
You may qualify if:
- Hemoglobin A1C of 5.7 or higher
You may not qualify if:
- Hemoglobin A1C of 5.6 or lower
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Missouri
Columbia, Missouri, 65211, United States
Holy Cross Church
Kansas City, Missouri, 64123, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor in Nursing
Study Record Dates
First Submitted
May 29, 2025
First Posted
June 17, 2025
Study Start
August 1, 2025
Primary Completion
May 15, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
May 7, 2026
Record last verified: 2025-06